Techsomed Overview
Techsomed leverages generative AI to transform ablation therapy, a minimally invasive technique for treating tumors, heart arrhythmias, and chronic pain. The company’s first offering, the BioTraceIO360 software suite, focuses primarily on liver tumor ablation procedures. Leveraging standard medical imaging modalities such as Ultrasound, CT, and MRI, Techsomed empowers physicians with tissue damage prediction, advanced patient-specific treatment planning, and interactive ablation procedure analysis. Techsomed secured FDA De-Novo clearance for its post-ablation tissue response prediction offering, positioning BioTrace as the first and only FDA-cleared solution of its kind. Complemented by a 510K clearance for ablation treatment planning and confirmation, these flagship products lay the foundation for the comprehensive BioTraceIO360 Solution. Operating globally, Techsomed maintains a subsidiary in Germany, housing an advanced R&D center—a spin-off from Fraunhofer, a leading German research institution specializing in imaging software solutions. Additionally, a subsidiary in Japan supports commercialization efforts in the Japanese and other Asian markets.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $12.9M |
| Last funding | $2.5M |
| Stage | B |
| Rounds | 5 |
| Investors | 9 |
Team Members
11
Employees: 11-50
Web & Social Links
| Website | techsomed.com |
Locations
Derech Meir Weisgal 2, Rehovot, Israel
Photos & Videos
3 item(s)
Techsomed Business
Sector
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
Platforms & InterfacesSoftwareTags (21)
bioconvergencehospitalsimage-processingminimally-invasivemonitoringreal-timeimagingultrasoundmedical-devices3d-technologyoncologycardiologydoctorshealthcare-providersclinicsdiagnosticsblood-pressurecancerdigital-healthcaredecision-supportsoftware-platformGeographic Markets
JapanChinaAsiaTechsomed Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
Techsomed Lifecycle
Cumulative Funding Raised Over Time
All Events
Techsomed News
11 articlesTechsomed Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 29 |
| Team members | 11 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Techsomed Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 514804343 |
| Crunchbase | techsomed |
| Phone | +97286198866 |
| Creator | Jenny Sotnik-Talisman |
| Creator email | genys30@yahoo.com |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2024-03-03T00:00:00.000Z |
| Created | 2014-07-16T00:00:00.000Z |
| Claimed | Yes |